within Pharmacolibrary.Drugs.ATC.A;

model A01AC03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.96,
    Cl             = 0.00022,
    adminDuration  = 600,
    adminMass      = 20 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.038799999999999994,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.018333333333333333,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A01AC03</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Hydrocortisone is a synthetic corticosteroid used primarily for its anti-inflammatory and immunosuppressive effects. It is employed in the treatment of conditions such as adrenal insufficiency, severe allergies, skin diseases, and as a topical agent in oral preparations for inflammation in the mouth. It is an approved and widely used medication.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers following oral administration.</p><h4>References</h4><ol><li><p>Czock, D, et al., &amp; Häussler, U (2005). Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. <i>Clinical pharmacokinetics</i> 44(1) 61–98. DOI:<a href=&quot;https://doi.org/10.2165/00003088-200544010-00003&quot;>10.2165/00003088-200544010-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15634032/&quot;>https://pubmed.ncbi.nlm.nih.gov/15634032</a></p></li><li><p>Leung, AKC, &amp; Barankin, B (2017). Herpes Labialis: An Update. <i>Recent patents on inflammation &amp; allergy drug discovery</i> 11(2) 107–113. DOI:<a href=&quot;https://doi.org/10.2174/1872213X11666171003151717&quot;>10.2174/1872213X11666171003151717</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28971780/&quot;>https://pubmed.ncbi.nlm.nih.gov/28971780</a></p></li><li><p>Derendorf, H, et al., &amp; Krieg, M (1991). Pharmacokinetics and oral bioavailability of hydrocortisone. <i>Journal of clinical pharmacology</i> 31(5) 473–476. DOI:<a href=&quot;https://doi.org/10.1002/j.1552-4604.1991.tb01906.x&quot;>10.1002/j.1552-4604.1991.tb01906.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2050835/&quot;>https://pubmed.ncbi.nlm.nih.gov/2050835</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A01AC03;
